| Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis : Insights From JAK, an International Registry Collaboration | Arthritis & rheumatology |  | | 2026 | 8 | 11 |
|
| Identification of individuals at high risk of developing rheumatoid arthritis : a balanced random forest model in a cohort of 1544 first-degree relatives | RMD open | | | 2025 | 28 | 85 |
|
| Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox inrheumatoid arthritis | ESC (Europan Society of Cardiology) Congress 2024 | | | 2024 | 13 | 0 |
|
| Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis | RMD open | | | 2024 | 117 | 102 |
|
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis | 92nd EAS (European Atherosclerosis Society) Congress | | | 2024 | 22 | 0 |
|
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis | Frontiers in cardiovascular medicine | | | 2024 | 128 | 282 |
|
| Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study | Frontiers in medicine | | | 2023 | 76 | 119 |
|
| A potential role for chlamydial infection in rheumatoid arthritis development | Rheumatology | | | 2023 | 100 | 286 |
|
| Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis | Frontiers in immunology | | | 2023 | 202 | 385 |
|
| Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases | Frontiers in immunology | | | 2023 | 139 | 106 |
|
| Peut-on prédire la polyarthrite rhumatoïde ? | Revue du rhumatisme monographies |  | | 2022 | 126 | 0 |
|
| Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling | Arthritis & rheumatology | | | 2022 | 141 | 178 |
|
| Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis | Rheumatology | | | 2021 | 386 | 579 |
|
| Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis | BMJ Open | | | 2021 | 365 | 251 |
|
| Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profiling | International Journal of Immunogenetics | | | 2021 | 223 | 0 |
|
| Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis | Arthritis Research and Therapy | | | 2020 | 422 | 617 |
|
| Measuring ACPA in the general population or primary care: is it useful? | RMD Open | | | 2020 | 248 | 240 |
|
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | | | 2020 | 339 | 9 |
|
| Prevotella copri in individuals at risk for rheumatoid arthritis | Annals of the Rheumatic Diseases | | | 2019 | 476 | 0 |
|
| Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance | Frontiers in Immunology | | | 2018 | 439 | 392 |
|
| Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis | Rheumatology | | | 2017 | 566 | 5 |
|
| The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis | Clinical Rheumatology | | | 2017 | 640 | 3 |
|
| Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | | | 2014 | 686 | 0 |
|
| The severity of experimental arthritis is independent of IL-36 receptor signaling | Arthritis research & therapy | | | 2013 | 642 | 385 |
|
| Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions | Journal of leukocyte biology | | | 2013 | 559 | 598 |
|
| Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency | Arthritis research & therapy | | | 2013 | 657 | 314 |
|
| Endogenous IL-1α is a chromatin-associated protein in mouse macrophages | Cytokine | | | 2013 | 652 | 1 |
|
| Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments | Arthritis and rheumatism | | | 2012 | 636 | 1 |
|
| Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis | European Journal of Immunology | | | 2012 | 635 | 3 |
|
| The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | Journal of leukocyte biology |  | | 2012 | 724 | 0 |
|
| IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells | Blood | | | 2012 | 895 | 1,105 |
|
| Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice | Annals of the rheumatic diseases | | | 2012 | 690 | 0 |
|
| IL-36R ligands are potent regulators of dendritic and T cells | Blood | | | 2011 | 671 | 0 |
|
| Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis | Arthritis and rheumatism | | | 2011 | 659 | 0 |
|
| Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice | The Journal of immunology | | | 2010 | 577 | 0 |
|
| Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist | Arthritis and rheumatism | | | 2010 | 632 | 0 |
|
| IL-1 pathways in inflammation and human diseases | Nature reviews. Rheumatology | | | 2010 | 757 | 1 |
|
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | | | 2009 | 669 | 0 |
|
| Production and functional role of Interleukin-1 receptor antagonist in immune and inflammatory responses in vivo | | | | 2009 | 1,194 | 1,162 |
|
| Interleukin-33 is biologically active independently of caspase-1 cleavage | The Journal of biological chemistry | | | 2009 | 696 | 573 |
|
